Regulation of matrix stiffness on the epithelial-mesenchymal transition of breast cancer cells under hypoxia environment
- PMID: 28382476
- DOI: 10.1007/s00114-017-1461-9
Regulation of matrix stiffness on the epithelial-mesenchymal transition of breast cancer cells under hypoxia environment
Abstract
Substrate stiffness and hypoxia are associated with tumor development and progression, respectively. However, the synergy of them on the biological behavior of human breast cancer cell is still largely unknown. This study explored how substrate stiffness regulates the cell phenotype, viability, and epithelial-mesenchymal transition (EMT) of human breast cancer cells MCF-7 under hypoxia (1% O2). TRITC-phalloidin staining showed that MCF-7 cells transformed from round to irregular polygon with stiffness increase either in normoxia or hypoxia. While being accompanied with the upward tendency from a 0.5- to a 20-kPa substrate, the percentage of cell apoptosis was significantly higher in hypoxia than that in normoxia, especially on the 20-kPa substrate. Additionally, it was hypoxia, but not normoxia, that promoted the EMT of MCF-7 by upregulating hypoxia-inducible factor-1α (HIF-1α), vimentin, Snail 1, and matrix metalloproteinase 2 (MMP 2) and 9 (MMP 9), and downregulating E-cadherin simultaneously regardless of the change of substrate stiffness. In summary, this study discovered that hypoxia and stiffer substrate (20 kPa) could synergistically induce phenotype change, apoptosis, and EMT of MCF-7 cells. Results of this study have an important significance on further exploring the synergistic effect of stiffness and hypoxia on the EMT of breast cancer cells and its molecular mechanism.
Keywords: Breast cancer cell; Epithelial-mesenchymal transition; Hypoxia; Phenotype; Substrate stiffness.
Similar articles
-
Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.Oncol Rep. 2014 Apr;31(4):1891-8. doi: 10.3892/or.2014.3022. Epub 2014 Feb 11. Oncol Rep. 2014. PMID: 24535079
-
Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.Oncol Rep. 2014 Jun;31(6):2561-8. doi: 10.3892/or.2014.3140. Epub 2014 Apr 16. Oncol Rep. 2014. PMID: 24737252
-
Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.Ann Diagn Pathol. 2016 Jun;22:1-11. doi: 10.1016/j.anndiagpath.2016.01.004. Epub 2016 Feb 23. Ann Diagn Pathol. 2016. PMID: 27180053
-
Epigenetic regulation of epithelial-mesenchymal transition by hypoxia in cancer: targets and therapy.Curr Pharm Des. 2015;21(10):1272-8. doi: 10.2174/1381612821666141211145610. Curr Pharm Des. 2015. PMID: 25506893 Review.
-
Tumorigenesis and Progression As A Consequence of Hypoxic TME:A Prospective View upon Breast Cancer Therapeutic Targets.Exp Cell Res. 2020 Oct 15;395(2):112192. doi: 10.1016/j.yexcr.2020.112192. Epub 2020 Jul 30. Exp Cell Res. 2020. PMID: 32738345 Review.
Cited by
-
HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling.World J Stem Cells. 2020 Jan 26;12(1):87-99. doi: 10.4252/wjsc.v12.i1.87. World J Stem Cells. 2020. PMID: 32110277 Free PMC article.
-
Biophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT.Glob Chall. 2022 Mar 20;6(6):2100094. doi: 10.1002/gch2.202100094. eCollection 2022 Jun. Glob Chall. 2022. PMID: 35712024 Free PMC article. Review.
-
Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis.Front Cell Dev Biol. 2022 Jun 14;10:862791. doi: 10.3389/fcell.2022.862791. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35774228 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials